SMITH & NEPHEW PLC (SNN) Stock

HealthcareMedical Devices Website

4 members of Congress disclosed 10 trades in SNN since 2015: 5 purchases and 5 sales, most recently Alan Armstrong (purchase, Mar 30, 2026). 4 of the hedge funds AlphaScala tracks reported SNN in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Millennium Management's at $17.88M.

Which members of Congress traded SMITH & NEPHEW PLC (SNN)?

Members
4
Disclosed trades
10
Purchases
5
Sales
5

Most recent: Alan Armstrong (purchase, Mar 30, 2026); records start Mar 25, 2015.

PoliticianTrade dateTypeAmount
Alan Armstrong
R-OK · Senate
2026-03-30purchase$1k – $15k
Lisa McClain
R-MI · House
2025-06-17sale$1k – $15k
Lisa McClain
R-MI · House
2025-06-09purchase$1k – $15k
Dan Goldman
D-NY · House
2023-07-10sale$15k – $50k
Tom MacArthur
R-NJ · House
2018-10-17purchase$1k – $15k
Tom MacArthur
R-NJ · House
2017-05-01sale$1k – $15k
Tom MacArthur
R-NJ · House
2017-01-09purchase$15k – $50k
Tom MacArthur
R-NJ · House
2016-12-07sale$15k – $50k

From STOCK Act periodic transaction reports. House filings as of Nov 9, 2026.

See all SNN political trades →

Which hedge funds own SNN?

From 13F filings
FundShares HeldPosition ValueChange vs prior Q
Millennium Management
Israel Englander
621K$17.88M+2892%
D.E. Shaw
David Shaw
543K$15.64M-40%
Bridgewater Associates
Ray Dalio
264K$7.60M-4%
Citadel
Ken Griffin
109K$3.15M+36%

13F holdings as of Jun 30, 2026

Explore all tracked funds →

SNN price chart

Powered by TradingView

What does SMITH & NEPHEW PLC do?

Smith & Nephew plc ADR represents American Depositary Receipts of Smith & Nephew plc, a prominent global medical technology company. The primary function of this asset is to enable U.S. investors to hold shares in Smith & Nephew, which is based in the United Kingdom, through a financial instrument traded on the New York Stock Exchange. Smith & Nephew is renowned for its innovations in advanced wound management, orthopedics, and sports medicine. It plays a significant role in the healthcare sector, particularly impacting hospitals, surgical centers, and medical professionals who rely on high-quality surgical and wound care products. By facilitating access to international equity, Smith & Nephew plc ADR helps in diversifying investors’ portfolios and contributes to the global integration of financial markets. Its market significance is underscored by its influence on medical technology advancements and its contribution to improving patient outcomes worldwide.

CEO
Dr. Deepak S. Nath Ph.D.
Employees
16,988
Ask about SNNAI research agent